Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Focus on Serotonin Uptake Inhibitor Research, Hardback Book

Focus on Serotonin Uptake Inhibitor Research Hardback

Edited by Anne C Shirley

Hardback

Description

The most significant class of antidepressants marketed in recent years is the selective serotonin re-uptake inhibitors (SSRIs).

Claims of decreased adverse effects (ADRs) and increased safety have led to extensive use of these drugs by non-psychiatrists.

The six SSRIs available in the United States are citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft).

The primary uses for the SSRIs include unipolar and bipolar major depression and all of the anxiety disorders.

However, controlled trials also support the use of SSRIs in the treatment of other psychiatric disorders including dysthymia, pre-menstrual dysphoria, bulimia nervosa, obesity, borderline personality disorder, alcoholism, rheumatic pain, and migraine headache.

This new book presents leading-edge research from throughout the world on this

Information

Save 18%

£230.99

£189.15

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information